Two-tier architecture-based grading for pancreatic cancer outperforms traditional grading

Area of Science:

• Oncology
• Surgical Pathology
• Cancer Grading Systems

Background:

• Pancreatic ductal adenocarcinoma (PDAC) grading is crucial for prognosis.
• Traditional grading systems, such as College of American Pathologists/American Joint Committee on Cancer (CAP/AJCC), have limitations in predicting patient outcomes.
• There is a need for more accurate and reproducible grading methods for PDAC.

Purpose of the Study:

• To evaluate a novel architecture-based grading system for PDAC.
• To compare the prognostic performance and reproducibility of the architecture-based system against traditional CAP/AJCC grading.

Main Methods:

• A cohort of 103 PDAC resections were graded using both CAP/AJCC guidelines and a novel architecture-based system (dispersed larger duct = low grade vs. dense smaller duct = high grade).
• Survival analyses (overall survival and recurrence-free survival) and interobserver variability were assessed.
• A separate validation cohort of 114 PDAC cases was used to confirm findings.

Main Results:

• The architecture-based grading system demonstrated significant differences in median overall survival (15 months for high-grade vs. 36 months for low-grade, P < .001).
• In contrast, CAP/AJCC grading showed no survival difference between well-differentiated and moderately differentiated tumors (P = .545).
• Architecture-based grading was prognostically significant for recurrence-free survival (P = .004) and showed substantial agreement (Cohen's ĸ = 0.710), outperforming CAP/AJCC grading (P = .226, ĸ = 0.488).

Conclusions:

• Grading pancreatic ductal adenocarcinoma based on architectural patterns provides superior prognostication compared to CAP/AJCC grading.
• The architecture-based system is more reproducible, showing substantial interobserver agreement.
• This novel grading approach offers improved accuracy for predicting patient outcomes in PDAC.